# TelyRx Finco Inc. — Form D

TelyRx Finco Inc. of Toronto, A6, a company, filed a Form D exempt-offering notice with the SEC on 2026-04-20. The offering totals $12.6M, of which $12.6M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2026-04-20
- Form: D
- Accession: 0000912282-26-000629
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $12.6M
- Amount sold: $12.6M
- Investors: 51
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-581152

## Issuer

- Name: TelyRx Finco Inc.
- CIK: 0002125491
- Entity type: Corporation
- Jurisdiction: ONTARIO, CANADA
- Address: 333 Bay Street, Suite 2400, Toronto, A6, M5H 2T6
- Phone: 800-878-1660

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| John Eric Cascio | Related Person | Toronto, A6 |
| Vanessa Slowey | Related Person | Toronto, A6 |

## More

- [CIK 2125491 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2125491&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000912282-26-000629.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.